Author Correction: An investigation into the mechanism of nobiletin’s inhibition of papillary thyroid cancer using network pharmacology analysis and experimental pharmacology

Q.-J. Du, Q. Li, R.-H. Zhou, H. Wang, Q. Yan, W.-J. Dang, J.-J. Guo

Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.

---

• Endocrinology

Correction to: European Review for Medical and Pharmacological Sciences 2023; 27 (4): 1553-1564. DOI: 10.26355/eurrev_202302_31398-PMID: 36876711-published online on February 15, 2023.

 

After publication, the authors applied some corrections to the galley proof:

–       The order of Table I and II has been inverted.

–       The scale bar of Figure 9A has been inserted in the Legend.

 

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause.

https://www.staging.europeanreview.org/article/31398

Free PDF Download